Skip to content

A clinical trial to study the effects of Kokilakshadi ghanavati and Kaishora guggulu in patients with joint pain due to the involvement of rakta.

EFFICACY OF KOKILAKSHADI GHANAVATI AND KAISHORA GUGGULU IN THE MANAGEMENT OF VATARAKTA(GOUT)-A RANDOMISED COMPARATIVE CLINICAL TRIAL.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051697
Enrollment
62
Registered
2023-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

Adhip Chand S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects showing the uric acid level between 7-11 mg/dl. subjects presenting with clinical features of vatarakta such as, pain swelling(katina,stabda) burning sensation(daha) malaise hot to touch affected skin becomes blackish red in colour(syava/tamra twacha) itching(kandu) kunchana(contracture) daha,toda,sphurana in sandhi subjects presenting with clinical features of gout such as, painful joint swelling redness of joint hyperuricemia(7-11 mg/dl)

Exclusion criteria

Exclusion criteria: subjects prediagnosed with autoimmune disease of joints patients with chronic alcoholic history hypothyroidism patient on immune suppressive drugs tumour lysis syndrome type 1 diabetes mellitus type 2 diabetus mellitus with complications patients with severe toxicity,ulceration,progressive gangrenous changes syphilis patient of vatarakta having, spread upto knee(aajanu) cracked skin(sphutita) broken skin(prabhinna) discharging(prasruta) paka with complications(upadravajushta)

Design outcomes

Primary

MeasureTime frame
reduction in serum uric acid level of the patient. improvement in signs and symptoms of the patient.Timepoint: assessment of signs and symptoms and serum uric acid level will be done 3 times;0th day,30th day,60th day.

Secondary

MeasureTime frame
improvement in quality of life of the patient.Timepoint: 2months

Countries

India

Contacts

Public ContactAdhip Chand S

All India Institute of Ayurveda

drrky68@gmail.com09412148437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026